A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Cancer Research

• Publication date

  2016-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-15-2081PMID 27076624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia

  2014cited by this paper
• PML nuclear bodies: regulation, function and therapeutic perspectives

  2014cited by this paper
• Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer

  2013cited by this paper
• Thrombospondin‐2 secreted by human umbilical cord blood‐derived mesenchymal stem cells promotes chondrogenic differentiation

  2013cited by this paper
• Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

  2012cited by this paper
• A metabolic prosurvival role for PML in breast cancer.

  2012cited by this paper
• Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells

  2011cited by this paper
• The connections between neural crest development and neuroblastoma.

  2011cited by this paper
• RAS oncogenes: weaving a tumorigenic web

  2011cited by this paper
• Prognostic impact of gene expression-based classification for neuroblastoma.

  2010cited by this paper
• ConsensusPathDB: toward a more complete picture of cell biology

  2010influential reference
• The tumor suppressor Pml regulates cell fate in the developing neocortex

  2009influential reference
• PML: a tumor suppressor essential for neocortical development

  2009cited by this paper
• Perspectives in PML: a unifying framework for PML function.

  2009cited by this paper
• Stemming out of a new PML era?

  2009cited by this paper
• In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin

  2008cited by this paper
• Activating mutations in ALK provide a therapeutic target in neuroblastoma

  2008cited by this paper
• Identification of ALK as a major familial neuroblastoma predisposition gene

  2008cited by this paper
• New insights into the role of PML in tumour suppression

  2008cited by this paper
• PML targeting eradicates quiescent leukaemia-initiating cells

  2008cited by this paper
• A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells

  2007cited by this paper
• Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

  2007cited by this paper
• Molecular biology of neuroblastoma

  2007cited by this paper
• PML and PML nuclear bodies: implications in antiviral defence.

  2007cited by this paper
• Identification of a tumour suppressor network opposing nuclear Akt function

  2006cited by this paper
• A CK2-dependent mechanism for degradation of the PML tumor suppressor.

  2006cited by this paper
• PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.

  2006influential reference
• Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q.

  2006cited by this paper
• PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR

  2006cited by this paper
• Characterization of endogenous human promyelocytic leukemia isoforms.

  2006cited by this paper
• Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

  2005cited by this paper
• 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.

  2005cited by this paper
• PML nuclear bodies: dynamic sensors of DNA damage and cellular stress

  2004cited by this paper
• Restoration of Promyelocytic Leukemia Protein-Nuclear Bodies in Neuroblastoma Cells Enhances Retinoic Acid Responsiveness

  2004cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003influential reference
• The International Neuroblastoma Pathology Classification.

  2003cited by this paper
• The role of PML in tumor suppression.

  2002cited by this paper
• Deconstructing PML‐induced premature senescence

  2002influential reference
• Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma.

  2002cited by this paper
• Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

  2002cited by this paper
• Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression

  2001cited by this paper
• International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors

  2001influential reference
• Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism

  2001cited by this paper
• PML is induced by oncogenic ras and promotes premature senescence.

  2000cited by this paper
• The International Neuroblastoma Pathology Classification (the Shimada system)

  1999cited by this paper
• Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity

  1999cited by this paper
• Molecular biology of neuroblastoma.

  1999cited by this paper
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

  1999cited by this paper
• Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer

  1999cited by this paper
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

  1999cited by this paper
• Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization

  1997cited by this paper
• Schwann cells in neuroblastoma.

  1995cited by this paper
• Inhibition of angiogenesis by thrombospondin-2.

  1995cited by this paper
• The PML growth-suppressor has an altered expression in human oncogenesis.

  1995cited by this paper
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

  1993cited by this paper
• Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.

  1993cited by this paper

• THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer

  2024cites this paper
• Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease.

  2024cites this paper
• USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression

  2024cites this paper
• Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

  2022cites this paper
• Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling

  2020cites this paper
• Engineered human mesenchymal stem cells for neuroblastoma therapeutics

  2019cites this paper
• The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)

  2018cites this paper
• PML: Regulation and multifaceted function beyond tumor suppression

  2018cites this paper
• Correction: A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

  2017cites this paper
• Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism

  2017cites this paper
• Biologie cellulaire et moléculaire

  2016cites this paper